Showing results (51-60 of 170) with videos related to

Sort By:
Pageof 17
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|June 5, 2023
Multimodal treatment and immune checkpoint inhibition in sinonasal mucosal melanoma: real-world data of a retrospective, single-center studyAgmal Scherzad, Manuel Stöth, Till J Meyer, et al.
The British Journal of Dermatology|September 4, 2025
Breaking primary checkpoint inhibitor resistance with intermittent alkylating chemotherapy in patients with metastatic melanoma - Results of a multicenter phase II studySebastian Haferkamp, Bastian Schilling, Carola Berking, et al.
Plos One|April 22, 2015
Corticosteroids augment BRAF inhibitor vemurafenib induced lymphopenia and risk of infectionWiebke Sondermann, Klaus G Griewank, Bastian Schilling, et al.
Cancers|October 14, 2022
Monitoring of Dabrafenib and Trametinib in Serum and Self-Sampled Capillary Blood in Patients with BRAFV600-Mutant MelanomaNora Isberner, Anja Gesierich, David Balakirouchenane, et al.
European Journal of Cancer (Oxford, England : 1990)|October 23, 2017
Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitisCindy Franklin, Isabelle Rooms, Melanie Fiedler, et al.
Frontiers in Oncology|April 1, 2021
Subgroup-Independent Mapping of Renal Cell Carcinoma-Machine Learning Reveals Prognostic Mitochondrial Gene Signature Beyond Histopathologic BoundariesAndré Marquardt, Antonio Giovanni Solimando, Alexander Kerscher, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 14, 2013
TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomasKlaus G Griewank, Bastian Schilling, Rajmohan Murali, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 2, 2022
Patient Preferences in Hidradenitis Suppurativa (APProach-HS): a discrete choice experimentKristin Faverio, Wiebke K Peitsch, Tatiana Görig, et al.
Patient Preference and Adherence|April 9, 2026
Patient Preferences in Hidradenitis Suppurativa Depend on Treatment Experience: Results from APProach-HSChristian Kromer, Kristin Faverio, Tatiana Görig, et al.
Scientific Reports|September 29, 2022
A preclinical model of cutaneous melanoma based on reconstructed human epidermisAnna Leikeim, Maximiliane Wußmann, Freia F Schmidt, et al.
Pageof 17